Gordon, K, R.B. Warren, A.B. Gottlieb, A Blauvelt, D Thaci, C Leonardi, Y Poulin, M Boehnlein, S Kavanagh, C Arendt, and K Reich. 2019. “Long-Term Efficacy of Certolizumab Pegol Dosed at 400 Mg Every Two Weeks in Patients With Plaque Psoriasis: Pooled 128-Week Data from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”. SKIN The Journal of Cutaneous Medicine 3 (November):S36. https://doi.org/10.25251/skin.3.supp.36.